Pfizer Inc and its German partner BioNTech SE said on Thursday they have filed for full approval of their COVID-19 vaccine to the US Food and Drug Administration to include adolescents aged 12 to 15.
Pfizer Inc and its German partner BioNTech SE said on Thursday they have filed for full approval of their COVID-19 vaccine to the US Food and Drug Administration to include adolescents aged 12 to 15.